The merger of CyBio AG into Analytik Jena AG became effective upon entry into the commercial register of Analytik Jena AG (commercial register of the Registry Court of Jena, HRB 200027). As a result, CyBio AG is dissolved as an independent company.
In the future, the Life Science business unit of Analytik Jena AG will continue CyBio Group's business in the areas of liquid handling and laboratory automation. The products will continue to be marketed under the independent CyBio brands.
In the coming years, Analytik Jena also anticipates expanding the liquid-handling area under the well-established product brand. All employees of the previous CyBio AG will be taken on by Analytik Jena with the merger.
"With the successful merger we have finally completed the multi-year integration process of CyBio AG into the Analytik Jena Group. As a result, we are combining the technological expertise and employee resources of both companies and are also in a position to configure our internal organizational structures much more effectively," said Klaus Berka, Chief Executive Officer of Analytik Jena AG.
Analytik Jena AG acquired all still outstanding shares of CyBio AG in connection with the merger. The overwhelming majority of shareholders of CyBio AG drafted a corresponding resolution to transfer the shares of the minority shareholders to Analytik Jena AG as the majority shareholder in return for payment of compensation in cash at the company's General Meeting on May 22, 2014.